Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
INR 1676.35
(1.25%)
INR 1676.35
(1.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 95.76 Billion INR | 13.01% |
| 2022 | 84.73 Billion INR | 158.91% |
| 2021 | 32.72 Billion INR | 12.7% |
| 2020 | 29.03 Billion INR | -22.87% |
| 2019 | 37.64 Billion INR | 41.25% |
| 2018 | 26.65 Billion INR | 27.19% |
| 2017 | 20.95 Billion INR | -69.91% |
| 2016 | 69.64 Billion INR | 53.21% |
| 2015 | 45.45 Billion INR | 0.14% |
| 2014 | 45.39 Billion INR | 44.5% |
| 2013 | 31.41 Billion INR | 5.31% |
| 2012 | 29.83 Billion INR | 12.28% |
| 2011 | 26.56 Billion INR | 46.29% |
| 2010 | 18.16 Billion INR | 34.82% |
| 2009 | 13.46 Billion INR | -28.28% |
| 2008 | 18.78 Billion INR | 21.09% |
| 2007 | 15.5 Billion INR | 84.6% |
| 2006 | 8.4 Billion INR | 46.63% |
| 2005 | 5.72 Billion INR | 43.09% |
| 2004 | 4 Billion INR | 21.05% |
| 2003 | 3.3 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 30.4 Billion INR | 7.21% |
| 2024 Q1 | 28.35 Billion INR | 6.82% |
| 2023 Q1 | 20.22 Billion INR | 1.92% |
| 2023 Q4 | 26.54 Billion INR | 5.18% |
| 2023 Q3 | 25.23 Billion INR | 6.24% |
| 2023 Q2 | 23.75 Billion INR | 17.45% |
| 2023 FY | 95.76 Billion INR | 13.01% |
| 2022 Q1 | 20.6 Billion INR | 190.5% |
| 2022 Q4 | 19.84 Billion INR | -8.38% |
| 2022 FY | 84.73 Billion INR | 158.91% |
| 2022 Q2 | 22.62 Billion INR | 9.77% |
| 2022 Q3 | 21.66 Billion INR | -4.25% |
| 2021 Q4 | -22.77 Billion INR | -210.61% |
| 2021 FY | 32.72 Billion INR | 12.7% |
| 2021 Q1 | 14.44 Billion INR | 61.51% |
| 2021 Q3 | 20.58 Billion INR | 0.58% |
| 2021 Q2 | 20.47 Billion INR | 41.74% |
| 2020 Q1 | -16.55 Billion INR | -514.07% |
| 2020 Q2 | 18.12 Billion INR | 209.49% |
| 2020 Q3 | 18.52 Billion INR | 2.19% |
| 2020 Q4 | 8.94 Billion INR | -51.73% |
| 2020 FY | 29.03 Billion INR | -22.87% |
| 2019 Q2 | 10.64 Billion INR | -23.31% |
| 2019 Q1 | 13.87 Billion INR | 118.2% |
| 2019 Q3 | 9.13 Billion INR | -14.15% |
| 2019 Q4 | 3.99 Billion INR | -56.23% |
| 2019 FY | 37.64 Billion INR | 41.25% |
| 2018 Q2 | -2.69 Billion INR | -125.5% |
| 2018 FY | 26.65 Billion INR | 27.19% |
| 2018 Q1 | 10.57 Billion INR | -19.23% |
| 2018 Q4 | 6.35 Billion INR | -48.8% |
| 2018 Q3 | 12.41 Billion INR | 560.63% |
| 2017 Q3 | 3.21 Billion INR | -64.74% |
| 2017 Q2 | 9.12 Billion INR | 314.66% |
| 2017 FY | 20.95 Billion INR | -69.91% |
| 2017 Q1 | -4.24 Billion INR | -134.72% |
| 2017 Q4 | 13.08 Billion INR | 307.05% |
| 2016 Q3 | 14.71 Billion INR | -34.15% |
| 2016 Q1 | 20.33 Billion INR | 43.61% |
| 2016 Q4 | 12.23 Billion INR | -16.86% |
| 2016 Q2 | 22.35 Billion INR | 9.9% |
| 2016 FY | 69.64 Billion INR | 53.21% |
| 2015 FY | 45.45 Billion INR | 0.14% |
| 2015 Q1 | 5.55 Billion INR | -37.49% |
| 2015 Q4 | 14.16 Billion INR | -8.33% |
| 2015 Q3 | 15.44 Billion INR | 50.16% |
| 2015 Q2 | 10.28 Billion INR | 85.07% |
| 2014 Q4 | 8.89 Billion INR | 124.94% |
| 2014 Q3 | 3.95 Billion INR | -80.72% |
| 2014 FY | 45.39 Billion INR | 44.5% |
| 2014 Q1 | 12.04 Billion INR | -20.97% |
| 2014 Q2 | 20.5 Billion INR | 70.2% |
| 2013 Q1 | -12.76 Billion INR | -229.35% |
| 2013 FY | 31.41 Billion INR | 5.31% |
| 2013 Q4 | 15.24 Billion INR | -0.45% |
| 2013 Q3 | 15.31 Billion INR | 12.39% |
| 2013 Q2 | 13.62 Billion INR | 206.75% |
| 2012 Q3 | 8.81 Billion INR | 175.72% |
| 2012 Q2 | 3.19 Billion INR | -59.82% |
| 2012 Q1 | 7.95 Billion INR | -3.01% |
| 2012 FY | 29.83 Billion INR | 12.28% |
| 2012 Q4 | 9.86 Billion INR | 11.94% |
| 2011 Q4 | 8.2 Billion INR | 22.73% |
| 2011 Q3 | 6.68 Billion INR | 11.8% |
| 2011 FY | 26.56 Billion INR | 46.29% |
| 2011 Q2 | 5.97 Billion INR | 19.31% |
| 2011 Q1 | 5.01 Billion INR | 0.0% |
| 2010 FY | 18.16 Billion INR | 34.82% |
| 2009 FY | 13.46 Billion INR | -28.28% |
| 2008 FY | 18.78 Billion INR | 21.09% |
| 2007 FY | 15.5 Billion INR | 84.6% |
| 2006 FY | 8.4 Billion INR | 46.63% |
| 2005 FY | 5.72 Billion INR | 43.09% |
| 2004 FY | 4 Billion INR | 21.05% |
| 2003 FY | 3.3 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bal Pharma Limited | 73.92 Million INR | -129447.09% |
| Achyut Healthcare Limited | 5.73 Million INR | -1670587.369% |
| Alkem Laboratories Limited | 17.95 Billion INR | -433.274% |
| Divi's Laboratories Limited | 16 Billion INR | -498.524% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 737.716% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -1933.685% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 48641.088% |
| Mankind Pharma Limited | 19.12 Billion INR | -400.622% |
| Medicamen Biotech Limited | 109.31 Million INR | -87507.538% |
| Medico Remedies Limited | 82.9 Million INR | -115404.71% |
| Megasoft Limited | -127.46 Million INR | 75228.897% |
| Procter & Gamble Health Limited | 2 Billion INR | -4664.842% |
| Piramal Pharma Limited | 178.2 Million INR | -53639.506% |
| Sequent Scientific Limited | -358.69 Million INR | 26798.207% |
| Sigachi Industries Limited | 571.8 Million INR | -16647.72% |
| Ajanta Pharma Limited | 8.16 Billion INR | -1073.332% |
| Brooks Laboratories Limited | -195.91 Million INR | 48979.282% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -4315.072% |
| Themis Medicare Limited | 435.23 Million INR | -21902.628% |
| Unichem Laboratories Limited | -704.74 Million INR | 13688.471% |
| Hester Biosciences Limited | 188.89 Million INR | -50598.184% |
| Venus Remedies Limited | 284.9 Million INR | -33512.184% |
| Indoco Remedies Limited | 984.6 Million INR | -9626.153% |
| Ind-Swift Limited | 142.31 Million INR | -67190.971% |
| Aarti Drugs Limited | 1.71 Billion INR | -5486.56% |
| Alpa Laboratories Limited | 167.76 Million INR | -56982.109% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -5829.28% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | -71.977% |
| Granules India Limited | 4.05 Billion INR | -2262.73% |
| Gufic Biosciences Limited | 861.35 Million INR | -11017.796% |
| Hikal Limited | 696.02 Million INR | -13658.771% |
| RPG Life Sciences Limited | 876.6 Million INR | -10824.458% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -3089.145% |
| Windlas Biotech Limited | 581.87 Million INR | -16357.937% |
| ZIM Laboratories Limited | 172.46 Million INR | -55426.835% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -2174.882% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -7023.693% |
| Jubilant Pharmova Limited | 771 Million INR | -12320.726% |
| Aurobindo Pharma Limited | 31.72 Billion INR | -201.811% |
| Bajaj HealthCare Limited | -837.93 Million INR | 11528.602% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -1350207.389% |
| Ipca Laboratories Limited | 5.47 Billion INR | -1649.59% |
| Lasa Supergenerics Limited | -217.3 Million INR | 44168.641% |
| Laurus Labs Limited | 1.6 Billion INR | -5864.734% |
| NATCO Pharma Limited | 13.88 Billion INR | -589.792% |
| Nectar Lifesciences Limited | 49.95 Million INR | -191619.319% |
| Shilpa Medicare Limited | 318.74 Million INR | -29944.299% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 1787.795% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | -478.151% |
| Wanbury Limited | 559.56 Million INR | -17014.034% |
| Wockhardt Limited | -4.63 Billion INR | 2168.333% |
| Strides Pharma Science Limited | -706.14 Million INR | 13661.588% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -12591.663% |
| Suven Life Sciences Limited | -1.05 Billion INR | 9213.739% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -21193.81% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -1455.062% |
| Eris Lifesciences Limited | 3.91 Billion INR | -2343.06% |
| Lupin Limited | 19.14 Billion INR | -400.208% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 2573.15% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -37730.072% |
| Valiant Laboratories Limited | 3.19 Million INR | -2996264.205% |
| Zydus Lifesciences Limited | 38.59 Billion INR | -148.125% |
| FDC Limited | 3.05 Billion INR | -3037.5% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -1632.881% |
| Novartis India Limited | 851.9 Million INR | -11141.202% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -42531.795% |
| Neuland Laboratories Limited | 3 Billion INR | -3091.287% |
| Morepen Laboratories Limited | 961.59 Million INR | -9858.808% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -65485.355% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 105663.235% |